The PROGRESS Trial 2021-01
Research payments
$18,829,262
Through program year 2025, $18,829,262 in research payments was reported against The PROGRESS Trial 2021-01, across 1,242 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,594,451 | 395 |
| 2024 | Research | $4,540,737 | 336 |
| 2023 | Research | $8,805,747 | 427 |
| 2022 | Research | $1,888,328 | 84 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Pirwitz Austin, TX Named on 57 payments
- Brian Lindman Nashville, TN Named on 53 payments
- Ramzi Khalil Pittsburgh, PA Named on 44 payments
- Edwin Ho Bronx, NY Named on 37 payments
- Bilal Murad Minneapolis, MN Named on 31 payments
- Philippe Genereux New York, NY Named on 28 payments
- Evelio Rodriguez Nashville, TN Named on 27 payments
- Justin Strote Loveland, CO Named on 25 payments
- Andrew Frutkin Rancho Mirage, CA Named on 23 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.